Michael Hoptroff

785 total citations
28 papers, 548 citations indexed

About

Michael Hoptroff is a scholar working on Dermatology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Michael Hoptroff has authored 28 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Dermatology, 10 papers in Molecular Biology and 4 papers in Infectious Diseases. Recurrent topics in Michael Hoptroff's work include Dermatology and Skin Diseases (10 papers), Nail Diseases and Treatments (4 papers) and Gut microbiota and health (3 papers). Michael Hoptroff is often cited by papers focused on Dermatology and Skin Diseases (10 papers), Nail Diseases and Treatments (4 papers) and Gut microbiota and health (3 papers). Michael Hoptroff collaborates with scholars based in United Kingdom, India and United States. Michael Hoptroff's co-authors include G. A. Turner, Clive R. Harding, Barry Murphy, David Arnold, Sally Grimshaw, Adrian Smith, Simon V. Avery, Hans‐Gerd Janssen, Myriam Sidibe and Julie A. Nicholson and has published in prestigious journals such as PLoS ONE, Applied and Environmental Microbiology and Clinical Microbiology Reviews.

In The Last Decade

Michael Hoptroff

27 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Hoptroff United Kingdom 14 200 118 118 56 53 28 548
Richa Sharma India 14 28 0.1× 86 0.7× 88 0.7× 91 1.6× 21 0.4× 81 577
Nida Akhtar India 14 117 0.6× 128 1.1× 201 1.7× 94 1.7× 9 0.2× 42 679
Keri Marshall United States 10 34 0.2× 208 1.8× 45 0.4× 166 3.0× 281 5.3× 18 837
Julia Hiller Germany 13 116 0.6× 132 1.1× 43 0.4× 30 0.5× 35 0.7× 36 527
Rajamohanan K Pillai United States 12 136 0.7× 109 0.9× 68 0.6× 24 0.4× 56 1.1× 25 511
Ritu Saini United States 13 85 0.4× 89 0.8× 37 0.3× 92 1.6× 67 1.3× 38 528
Esther A. Balogh Denmark 14 244 1.2× 71 0.6× 22 0.2× 82 1.5× 94 1.8× 37 567
Shu‐Han Yu Taiwan 16 43 0.2× 240 2.0× 68 0.6× 127 2.3× 44 0.8× 42 756
Alfredo Molina‐Berríos Chile 14 9 0.0× 110 0.9× 118 1.0× 48 0.9× 35 0.7× 27 444
Kerryn A Greive Australia 12 170 0.8× 63 0.5× 14 0.1× 28 0.5× 8 0.2× 21 421

Countries citing papers authored by Michael Hoptroff

Since Specialization
Citations

This map shows the geographic impact of Michael Hoptroff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hoptroff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hoptroff more than expected).

Fields of papers citing papers by Michael Hoptroff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hoptroff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hoptroff. The network helps show where Michael Hoptroff may publish in the future.

Co-authorship network of co-authors of Michael Hoptroff

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hoptroff. A scholar is included among the top collaborators of Michael Hoptroff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hoptroff. Michael Hoptroff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pitol, Ana K., et al.. (2025). SARS-CoV-2 survival on skin and its transfer from contaminated surfaces. PLoS ONE. 20(6). e0325235–e0325235.
2.
3.
Thomas, Jordan, et al.. (2024). Development of a pseudo-typed virus particle based method to determine the efficacy of virucidal agents. Scientific Reports. 14(1). 2174–2174. 1 indexed citations
4.
Pitol, Ana K., et al.. (2023). Persistence of SARS-CoV-2 and its surrogate, bacteriophage Phi6, on surfaces and in water. Applied and Environmental Microbiology. 89(11). e0121923–e0121923. 5 indexed citations
5.
Murphy, Barry, et al.. (2023). Bioprospecting the Skin Microbiome: Advances in Therapeutics and Personal Care Products. Microorganisms. 11(8). 1899–1899. 19 indexed citations
6.
Murphy, Barry, Michael Hoptroff, David Arnold, et al.. (2023). Compositional Variations between Adult and Infant Skin Microbiome: An Update. Microorganisms. 11(6). 1484–1484. 7 indexed citations
7.
Anderson, Enyia R., Edward I. Patterson, Ana K. Pitol, et al.. (2022). CPC-containing oral rinses inactivate SARS-CoV-2 variants and are active in the presence of human saliva. Journal of Medical Microbiology. 71(2). 17 indexed citations
8.
Murphy, Barry, Sally Grimshaw, Michael Hoptroff, et al.. (2022). Alteration of barrier properties, stratum corneum ceramides and microbiome composition in response to lotion application on cosmetic dry skin. Scientific Reports. 12(1). 5223–5223. 37 indexed citations
9.
Losasso, Valeria, Khushbu Agarwal, A.K. Majumdar, et al.. (2021). Small molecules enhance the potency of natural antimicrobial peptides. Biophysical Journal. 121(3). 491–501. 8 indexed citations
10.
Murphy, Barry, et al.. (2021). In-vivo impact of common cosmetic preservative systems in full formulation on the skin microbiome. PLoS ONE. 16(7). e0254172–e0254172. 18 indexed citations
11.
Carrieri, Anna Paola, Niina Haiminen, Laura‐Jayne Gardiner, et al.. (2021). Explainable AI reveals changes in skin microbiome composition linked to phenotypic differences. Scientific Reports. 11(1). 4565–4565. 64 indexed citations
12.
McBain, Andrew J., Catherine O’Neill, Alejandro Amézquita, et al.. (2019). Consumer Safety Considerations of Skin and Oral Microbiome Perturbation. Clinical Microbiology Reviews. 32(4). 16 indexed citations
13.
Grimshaw, Sally, et al.. (2019). The diversity and abundance of fungi and bacteria on the healthy and dandruff affected human scalp. PLoS ONE. 14(12). e0225796–e0225796. 59 indexed citations
14.
Ji, Chengdong, et al.. (2017). Ex-vivo measurement of scalp follicular infundibulum delivery of zinc pyrithione and climbazole from an anti-dandruff shampoo. Journal of Pharmaceutical and Biomedical Analysis. 143. 26–31. 13 indexed citations
15.
Miao, Miao, et al.. (2015). Sensitive and simultaneous quantification of zinc pyrithione and climbazole deposition from anti-dandruff shampoos onto human scalp. Journal of Chromatography B. 1003. 22–26. 13 indexed citations
16.
Nicholson, Julie A., Mojgan Naeeni, Michael Hoptroff, et al.. (2014). An investigation of the effects of a hand washing intervention on health outcomes and school absence using a randomised trial in Indian urban communities. Tropical Medicine & International Health. 19(3). 284–292. 60 indexed citations
17.
Matheson, et al.. (2014). A high glycerol-containing leave-on scalp care treatment to improve dandruff.. PubMed. 12(3). 155–61. 3 indexed citations
19.
Turner, G. A., Michael Hoptroff, & Clive R. Harding. (2012). Stratum corneum dysfunction in dandruff. International Journal of Cosmetic Science. 34(4). 298–306. 101 indexed citations
20.
Hoptroff, Michael, Simon V. Avery, & Simon Thomas. (1997). Influence of altered plasma membrane fatty acid composition on cesium transport characteristics and toxicity inSaccharomyces cerevisiae. Canadian Journal of Microbiology. 43(10). 954–962. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026